Discontinued — last reported Q1 '18
ConocoPhillips Allowance for Doubtful Accounts Receivable (Current) increased by 33.3% to $4.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 42.9%, from $7.00M to $4.00M. Over 5 years (FY 2020 to FY 2025), Allowance for Doubtful Accounts Receivable (Current) shows relatively stable performance with a 0.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A significant increase relative to receivables may signal deteriorating customer credit quality or economic headwinds in specific markets.
This is a contra-asset account representing the estimated amount of accounts receivable that the company expects will no...
Standard across all industries; peers in the medical device sector typically maintain low levels unless operating in high-risk emerging markets.
allowance_for_doubtful_accounts_receivable_current| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.00M | $2.00M | $2.00M | $2.00M | $2.00M | $3.00M | $3.00M | $3.00M | $3.00M | $4.00M | $4.00M | $4.00M | $7.00M | $7.00M | $6.00M | $3.00M | $4.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +50.0% | +0.0% | +0.0% | +0.0% | +33.3% | +0.0% | +0.0% | +75.0% | +0.0% | -14.3% | -50.0% | +33.3% |
| YoY Change | — | — | — | — | +0.0% | +50.0% | +50.0% | +50.0% | +50.0% | +33.3% | +33.3% | +33.3% | +133.3% | +75.0% | +50.0% | -25.0% | -42.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.